Lumen Bioscience has filed a notice of an exempt offering of securities to raise $33,000,000.00 in New Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Lumen Bioscience is raising $33,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brian Finrow played a key role…